循证管理路径对中老年血脂异常患者的干预效果评价OA

Objective:To explore the intervention effect of a chronic disease management model based on clinical guidelines on middle-aged and elderly patients with dyslipidemia.Methods:A total of 183 middle-aged and elderly patients with dyslipidemia who underwent physical examination at the Talent Health Management Center of Yichang Central People's Hospital from April 2022 to April 2023 were selected and randomly divided into a control group(n=87)and an intervention group(n=96).The control group received only lipid-lowering treatment,while the intervention group received chronic disease management based on the"Chinese Guidelines for Lipid Management(Primary Care Edition,2024)"in addition to the same treatment as the control group.A one-year follow-up was conducted.The improvement in dyslipidemia indicators was compared between the two groups.Results:After one year of follow-up,the intervention group showed significant reductions in the proportions of unhealthy lifestyle behaviors,including physical inactivity(37.50％vs 54.17％)and overweight or obesity(47.92％vs 71.88％).Medication adherence(96.88％vs 89.58％),blood pressure control rate(64.58％vs 48.96％),and low-density lipoprotein cholesterol(LDL-C)target attainment rate(92.71％vs 0％)were significantly improved compared with baseline(all P＜0.05).Compared with the control group,the intervention group demonstrated better outcomes in terms of unhealthy lifestyle behaviors(physical inactivity:37.50％vs 57.47％,overweight or obesity:47.92％vs 68.97％),medication adherence(96.88％vs 82.76％),and target attainment rates for total cholesterol(TC)(97.92％vs 72.41％),triglycerides(TG)(83.33％vs 68.97％),and LDL-C(92.71％vs 41.38％)(all P＜0.05).Conclusion:Implementing chronic disease management in patients with dyslipidemia can effectively intervene in risk factors such as lack of exercise,and overweight or obesity,while improving medication adherence and enhancing control over indicators such as TC,TG,and LDL-C compliance rates.This study provides practical experience and theoretical basis for the construction of the chronic disease management model for dyslipidemia.